Literature DB >> 9325095

Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.

A Alvarez1, C Opazo, R Alarcón, J Garrido, N C Inestrosa.   

Abstract

Acetylcholinesterase (AChE), an enzyme involved in the hydrolysis of the neurotransmitter acetylcholine, consistently colocalizes with the amyloid deposits characteristic of Alzheimer's disease and may contribute to the generation of amyloid proteins and/or physically affect fibril assembly. In order to identify the structural domains of the amyloid-beta-peptide (Abeta) involved in the aggregation induced by AChE, we have studied the effect of this cholinergic enzyme on Abeta peptide fragments of different sizes. AChE enhanced the aggregation of the Abeta(12-28) and Abeta(25-35) peptides but not of the Abeta(1-16) fragment. The inductive effect of AChE on the aggregation of Abeta(12-28) was abolished by the presence of either Abeta(1-16) or Abeta(9-21). The effect of the enzyme was also analysed using two different mutant fragments, possessing a low and the other a high capacity for fibrillogenesis. The fragments used were Abeta(12-28)Val18-->Ala and Abeta(12-28)Glu22-->Gln, respectively. AChE was able to promote the aggregation of these fragments in a very specific way and both mutant peptides were able to form amyloid fibrils, as revealed by negative staining under the electron microscope. Binding assays indicated that AChE was bound to Abeta(12-28), as well as to the Abeta(1-16) peptide. AChE was seen to form strong complexes with the Abeta(12-28) fibrils as such complexes stained positively for both thioflavine-T and AChE activity, were resistant to high ionic strength treatment, and were partially sensitive to detergents, suggesting that hydrophobic interactions may play a role in the stabilization of the AChE-Abeta complex. Our results suggest that such amyloid-AChE complexes are formed when AChE interacts with the growing amyloid fibrils and accelerates the assembly of Abeta peptides. This is consistent with the fact that AChE is known to be present within Abeta deposits including the pre-amyloid diffuse and mature senile plaques found in Alzheimer's brain. Copyright 1997 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9325095     DOI: 10.1006/jmbi.1997.1245

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  50 in total

Review 1.  Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?

Authors:  M Zimmermann
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model.

Authors:  Chun-Yan Wang; Wei Zheng; Tao Wang; Jing-Wei Xie; Si-Ling Wang; Bao-Lu Zhao; Wei-Ping Teng; Zhan-You Wang
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

3.  A computational view on the significance of E-ring in binding of (+)-arisugacin A to acetylcholinesterase.

Authors:  Ziyad F Al-Rashid; Richard P Hsung
Journal:  Bioorg Med Chem Lett       Date:  2015-06-27       Impact factor: 2.823

4.  Amyloid-beta-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Abeta peptide. Implications for the pathogenesis of Alzheimer's disease.

Authors:  Margarita C Dinamarca; Juan P Sagal; Rodrigo A Quintanilla; Juan A Godoy; Macarena S Arrázola; Nibaldo C Inestrosa
Journal:  Mol Neurodegener       Date:  2010-01-18       Impact factor: 14.195

5.  Wnt-5a occludes Abeta oligomer-induced depression of glutamatergic transmission in hippocampal neurons.

Authors:  Waldo Cerpa; Ginny G Farías; Juan A Godoy; Marco Fuenzalida; Christian Bonansco; Nibaldo C Inestrosa
Journal:  Mol Neurodegener       Date:  2010-01-18       Impact factor: 14.195

6.  Butyrylcholinesterase attenuates amyloid fibril formation in vitro.

Authors:  Sophia Diamant; Erez Podoly; Assaf Friedler; Hagai Ligumsky; Oded Livnah; Hermona Soreq
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-26       Impact factor: 11.205

7.  Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression.

Authors:  Y Li; L Liu; J Kang; J G Sheng; S W Barger; R E Mrak; W S Griffin
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

8.  Neuroprotective Role of Novel Triazine Derivatives by Activating Wnt/β Catenin Signaling Pathway in Rodent Models of Alzheimer's Disease.

Authors:  Anshuman Sinha; Riyaj S Tamboli; Brashket Seth; Ashish M Kanhed; Shashi Kant Tiwari; Swati Agarwal; Saumya Nair; Rajani Giridhar; Rajnish Kumar Chaturvedi; Mange Ram Yadav
Journal:  Mol Neurobiol       Date:  2014-09-26       Impact factor: 5.590

9.  BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia.

Authors:  Alessandra Bizzarro; V Guglielmi; R Lomastro; A Valenza; A Lauria; C Marra; M C Silveri; F D Tiziano; C Brahe; C Masullo
Journal:  J Neural Transm (Vienna)       Date:  2010-03       Impact factor: 3.575

Review 10.  Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease.

Authors:  Elena Anahi Bignante; Florencia Heredia; Gerardo Morfini; Alfredo Lorenzo
Journal:  Neurobiol Aging       Date:  2013-05-25       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.